D63.1
Anemia in chronic kidney disease
Clinical Classification Guidelines
Inclusion Terms
- Erythropoietin resistant anemia (EPO resistant anemia)
Code First
- underlying chronic kidney disease (CKD) (N18.-)
Medical Intelligence & Overview
Anemia in chronic kidney disease (CKD), classified under ICD-10 code D63.1, is a common complication affecting many individuals with impaired kidney function. It occurs when the kidneys are unable to produce enough erythropoietin, a hormone essential for red blood cell production. This deficiency leads to reduced oxygen-carrying capacity in the blood, causing various symptoms and health issues. Addressing anemia in CKD is vital for improving quality of life and preventing further complications.
Causes & Symptoms
Clinical Causes: Decreased erythropoietin production due to damaged kidneys Chronic inflammation related to CKD Nutritional deficiencies, such as iron, vitamin B12, or folate deficiency Bone marrow suppression or damage Use of certain medications that suppress bone marrow activity Blood loss, often related to dialysis procedures or gastrointestinal bleeding Erythropoietin resistant anemia, where the body's response to erythropoietin is diminished
Key Symptoms: Fatigue and weakness Shortness of breath during exertion Pallor (pale skin and mucous membranes) Dizziness or lightheadedness Cold hands and feet Headaches Heart palpitations Decreased exercise tolerance
Diagnostic & Treatment
Diagnosis Path: Diagnosis involves a combination of medical history review, physical examination, and laboratory tests. Tests typically include blood tests such as: - Complete blood count (CBC) to evaluate red blood cell levels and hemoglobin concentration - Serum iron, ferritin, and total iron-binding capacity to assess iron status - Vitamin B12 and folate levels - Reticulocyte count to gauge bone marrow activity - Erythropoietin level assessment - Kidney function tests, including serum creatinine and estimated glomerular filtration rate (eGFR) Additional tests may be performed to identify other contributing factors or underlying causes.
Treatment Protocols: Managing anemia in CKD involves addressing its underlying causes and restoring healthy red blood cell levels. Treatments may include: - **Erythropoiesis-stimulating agents (ESAs):** Medications designed to stimulate red blood cell production in the bone marrow - **Iron supplementation:** Oral or intravenous iron to correct iron deficiency, which is common in CKD patients - **Vitamin B12 and folate supplementation:** To treat deficiencies that may contribute to anemia - **Blood transfusions:** In cases of severe anemia or when rapid correction is necessary - **Managing underlying kidney disease:** Improving kidney function can help reduce anemia severity - **Addressing inflammation and other contributors:** Such as controlling infections or reducing medication side effects Each treatment plan is tailored to the individual's specific condition and needs, often involving collaboration between nephrologists and hematologists.
Clinical Advice & FAQs
Billing Guidance
Is D63.1 a billable ICD-10 code?
Yes, D63.1 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report D63.1?
Clinical documentation must specify the nature of Anemia in chronic kidney disease and any associated comorbidities for accurate reporting.
Cite this Clinical Reference